Knowledge Hub

Sickle-cell Anemia Therapeutics market in the US to grow at a CAGR of 17.10 % over the period 2014-2019

Press Release   •   Nov 25, 2016 05:16 EST has recently announced the addition of a market study “ Railway Infrastructure Spending Market in Brazil 2015-2019 ”, is a comparative analysis of the global market.

About Sickle-cell Anemia

Sickle-cell anemia is a disease characterized by the presence of sickle-shaped erythrocytes. While normal erythrocytes have a life span of 120 days, sickle-shaped erythrocytes die within 10 to 20 days. The bone marrow is unable to compensate for the excessive loss of erythrocytes, thereby leading to anemia. It is an inheritable disorder passed on across generations. The prevalence of the sickle-cell gene varies between different ethnic groups and geographical locations.

TechNavio's analysts forecast the Sickle-cell Anemia Therapeutics market in the US to grow at a CAGR of 17.10 percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the Sickle-cell Anemia Therapeutics market in the US for the period 2015-2019. To calculate the market size, the report considers the revenue generated through the sales of the US FDA-approved drugs used for the treatment of sickle-cell anemia.

TechNavio's report, Sickle-cell Anemia Therapeutics Market in US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. It covers the Sickle-cell Anemia Therapeutics market landscape in the US and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Vendors

Bristol-Myers Squibb

Future Prominent Vendors


Bluebird Bio

Daiichi Sankyo

Eli Lilly

Emmaus Medical


HemaQuest Pharmaceuticals

Mast Therapeutics

Merck Sharp & Dohme

Download The sample Copy Of This Report:


Selexys Pharmaceuticals

Market Driver

Unmet Medical Needs

For a full, detailed list, view our report

Market Challenge

Side Effects Associated with Current Therapies

For a full, detailed list, view our report

Market Trend

Increased Focus on Adult Patients

For a full, detailed list, view our report

Key Questions Answered in this Report

What will the market size be in 2019 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

Table Of Content

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offering

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Disease Overview

06. Introduction

07. Market Landscape

07.1 Market Overview

07.2 Market Size and Forecast

07.3 Five Forces Analysis

08. Buying Criteria

09. Market Growth Drivers

10. Drivers and their Impact

11. Market Challenges

12. Impact of Drivers and Challenges

13. Market Trends

14. Trends and their Impact

15. Vendor Landscape

15.1 Competitive Scenario

15.1.1 Key News

15.1.2 Mergers and Acquisitions

15.2 Pipeline Analysis

15.3 Market Share Analysis 2014

16. Future Prominent Vendors

17. Key Vendor Analysis

17.1 Bristol-Myers Squibb

17.1.1 Key Facts

17.1.2 Business Overview

17.1.3 Key Product Offerings

17.1.4 Revenue by Geography

17.1.5 Business Strategy

17.1.6 Key Information

17.1.7 SWOT Analysis

18. Other Reports in this Series